Highlights from MDS and Nonmalignant Hematology  New drugs for MDS: Rigosertib, Luspatercept, Ibrutnib

Highlights from MDS and Nonmalignant Hematology New drugs for MDS: Rigosertib, Luspatercept, Ibrutnib

User Photo
moasc

2 years
95 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Kanwarpal Kahlon, MD, from Ronald Reagan UCLA Medical Center talks Highlights from MDS and Nonmalignant Hematology New drugs for MDS: Rigosertib, Luspatercept, Ibrutnib at MOASCs Spotlight On® Hematology in Huntington Beach.
Up Next Autoplay